Have you ever put off talking to your significant other about expensive-but-necessary home repairs, for fear they'll hit the (leaking) roof? Most of us have, and if we haven't, we've put off some similar difficult conversation.
When the conversation involves a faltering clinical trial, the urge to avoid conflict becomes stronger still. But the longer you avoid that difficult conversation, the greater the risk your trial progresses from faltering to failure. And the deeper a trial's problems, the more likely you'll have to ask for a substantial budget increase—another difficult conversation.
Our research shows at least 33% of trials are at risk of failure. Some of that risk is attributable to refusing to undertake corrective action or not communicating that a trial is in jeopardy. Many of these trials fail to complete, but yours doesn't have to.
Early intervention, whether through an outside rescue or an internal reshuffle, is cheaper, faster, and has a much higher probability of success than waiting until the bitter end. Early intervention is even more critical when you consider the return—not return on investment, but return on intervention.